| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 161.28M | — |
| Operating expense | — | — |
| Net income | -8.24M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, STLN returned +61.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +71.9% |
| 1 year | +61.5% |
| 5 years | -38.4% |
| All-time high | $10.91 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in STLN would be worth today ›No. The Oncology Institute, Inc. has not paid a dividend in the past 12 months.
The Oncology Institute, Inc. stock trades on NASDAQ under the ticker symbol STLN.
The Oncology Institute, Inc. is part of the Healthcare sector.
The Oncology Institute, Inc. has a market cap of 623.73M USD, based on the latest quote.
